Deadline: 06-Apr-2026
The Pfizer Fellowship Grant Program provides up to USD 90,000 to U.S.-based accredited academic institutions to support one-year headache medicine fellowship programs. The funding strengthens clinical practice, independent research, and education in headache medicine, particularly in underserved regions facing workforce shortages. Applications are due 6 April 2026, with awards announced in May 2026 and fellowships beginning June 2026 or later.
The Pfizer Fellowship Grant Program funds headache medicine fellowship programs at accredited academic institutions across the United States.
The program supports workforce development, clinical excellence, independent research, and mentorship in headache medicine, especially in regions with limited training programs and healthcare inequities.
Funding is awarded to institutions, not individuals.
Program Overview
The grant is designed to:
-
Strengthen headache medicine clinical practice
-
Advance independent research
-
Improve medical education and training
-
Address healthcare disparities
-
Expand fellowship access in underserved states
The initiative prioritizes workforce shortages and inequities in access to specialized headache care.
Funding Details
Grant Amount: Up to USD 90,000
Funding Duration: One year
Funding Use: Fellow’s salary and benefits only
Restrictions:
-
No overhead or indirect costs
-
No institutional infrastructure expenses
-
No allocation to Pfizer business interests
-
No billing of supported clinical time as patient care
Research funded must be independent and not related to pharmaceutical product evaluation.
Eligible Applicants
Eligible institutions must:
-
Be accredited academic institutions
-
Be based in the United States
-
Have established fellowship programs
-
Provide strong mentorship and structured training
-
Include independent research components
Institutions must not identify a specific fellow in the application.
All fellows must:
-
Be authorized to work in the United States
-
Comply with transparency requirements, including the U.S. Physician Payments Sunshine Act
Focus Areas
The program prioritizes fellowship programs that:
-
Advance scientific understanding of headache disorders
-
Strengthen research and education in headache medicine
-
Address healthcare disparities and social determinants of health
-
Serve underserved or high-need populations
-
Expand fellowship access in states with limited training programs
Research Scope Requirements
Supported research must be:
-
Independent in nature
-
Observational or outcomes-based
-
Focused on improving disease understanding
-
Focused on improving patient health outcomes
Excluded research types:
-
Pharmaceutical product evaluation
-
Basic science research
-
Industry-influenced clinical trials
The program emphasizes real-world evidence and clinical impact.
Eligible Prospective Fellows
Although institutions apply, fellowship candidates should be:
-
Physicians holding an MD or DO degree
-
Eligible for certification through the United Council for Neurologic Subspecialties (UCNS) upon fellowship completion
Physicians from the following specialties may also qualify:
-
Primary care
-
Emergency medicine
-
Obstetrics and gynecology
-
Other non-neurology specialties
The goal is to expand headache medicine expertise beyond traditional neurology pathways.
How to Apply (Step-by-Step)
Step 1: Confirm Institutional Eligibility
Ensure your institution:
-
Is accredited
-
Has an established headache medicine fellowship
-
Includes structured mentorship and independent research
Step 2: Develop Fellowship Proposal
Your proposal should clearly describe:
-
Fellowship goals and objectives
-
Population health needs addressed
-
Clinical training (if included)
-
Research design and methodology
-
Mentorship structure
-
Training framework
-
Available institutional resources
Do not name a fellow in the application.
Step 3: Prepare Budget
Budget must:
-
Not exceed USD 90,000
-
Cover only fellow salary and benefits
-
Exclude overhead or indirect costs
Step 4: Submit Application
Submission Deadline: 6 April 2026
Applications will undergo competitive review by an expert panel.
Step 5: Review and Notification
Review criteria include:
-
Fellowship objectives
-
Community and patient need
-
Program structure
-
Mentoring quality
-
Training opportunities
-
Institutional capacity
Applicants may be contacted for clarification.
Award notifications are expected in May 2026.
Project Timeline
Application Deadline: 6 April 2026
Award Notification: May 2026
Project Start Date: June 2026 or later
Project End Date: June 2027 or later (depending on approved timeline)
Fellowship duration: One year
Why This Program Matters
Headache disorders, including migraine and chronic headache conditions, represent a major public health burden in the United States.
However, many states face:
-
Shortages of trained headache specialists
-
Limited fellowship programs
-
Unequal access to specialized care
-
Persistent healthcare disparities
This grant strengthens the national workforce pipeline and promotes equitable access to evidence-based headache medicine.
By investing in academic fellowship programs, the initiative enhances long-term clinical expertise and research capacity.
Common Mistakes to Avoid
-
Naming a specific fellow in the application
-
Including indirect costs or overhead in the budget
-
Proposing basic science or pharmaceutical product evaluation research
-
Weak mentorship structure
-
Failing to address healthcare disparities or workforce gaps
-
Unclear research design or training framework
Strong proposals demonstrate clear health impact, robust mentorship, and institutional readiness.
Frequently Asked Questions (FAQs)
1. Who applies for this grant?
U.S.-based accredited academic institutions with established headache medicine fellowship programs.
2. How much funding is available?
Up to USD 90,000 for one year, covering only the fellow’s salary and benefits.
3. Can institutions include overhead costs?
No. Funding cannot be used for indirect costs, overhead, or infrastructure expenses.
4. Can the research focus on pharmaceutical product evaluation?
No. Research must be independent and cannot evaluate specific pharmaceutical products.
5. Can clinical training be included?
Yes, but it is not required. Any supported clinical time must not be billed as patient care.
6. Are non-neurology physicians eligible as fellows?
Yes. Physicians from primary care, emergency medicine, obstetrics and gynecology, and other specialties may be eligible if they plan to pursue UCNS certification.
7. When will funding decisions be announced?
Funding decisions are expected in May 2026.
Conclusion
The Pfizer Fellowship Grant Program offers up to USD 90,000 to strengthen headache medicine fellowship programs across the United States.
By supporting independent research, structured mentorship, and workforce expansion in underserved regions, the program addresses critical gaps in headache care and promotes health equity.
Eligible academic institutions should prepare comprehensive, mentorship-driven proposals before the 6 April 2026 deadline to enhance the future of headache medicine training and research.
For more information, visit Pfizer.









































